Which nonopioid prescription drugs are ripe for abuse? There’s new clarity on multiple sclerosis therapy. How infections boost Sjogren's syndrome risk. And bum kidneys shouldn’t stop dabigatran reversal.
A call to push pause on a Medicare payment program, it's been a busy week at the FDA, ambulatory blood pressure measures outperform the office, and are fast food swamps to blame for more type 1 diabetes?
The potential for enhanced recovery after gynecology surgery, a group of doctors say no to pot for sleep apnea, cardiovascular risk is similar across arthritis subtypes, and what's the best antithrombotic therapy after TAVI?
Can a nasal spray reverse suicidality? Smoking boosts heart failure risk in black patients. Respiratory infections increase risk of heart attack and stroke. And pain relievers and inflammatory bowel disease? It's complicated.
Herpes zoster boosts short-term stroke and TIA risk. Americans don’t know about cancer drug shortages – but they want to. Complication rates rise after uterine fibroid morcellation’s boxed warning. And marijuana use may spur change in safety-sensitive industries.
Doctors weigh in on Medicaid work requirements. Could a patch counter eating disorders in female athletes? Zika’s sexual contact risk may be less than feared. And asthma is flourishing in a surprising location.
Is it time to let more pregnant women into drug trials? Epilepsy increases the risk of unnatural death. Can exercise counter genetic risk in heart disease? And health IT under-users still outnumber super-users.
From weekend warriors to pros, athletes are plagued by skin disorders. CMS finalizes measures to help combat the opioid crisis. Enrollment slides on health exchanges in 2018, and the sensitivity of vibration-based neuropathy detectors varies widely.
Antibiotic resistance leads to ‘nightmare’ bacteria. PPIs aren’t responsible for cognitive decline. Levothyroxine comes with risks for older patients. And Medicare formulary changes could be on the way.
Could gut bacteria trigger lupus? A simple ratio could uncover the cause of orthostatic hypotension. Does certolizumab have an unfair infection reputation? And how acid suppressors in infancy fuel allergies later on.
Does more marijuana mean fewer opioids? Acutely ill patients may not get enough VTE prophylaxis. Psoriatic arthritis patients aren’t sticking with biologics. And how many patients may be hiding from medical care?
How gastric bypass tames diabetes. New efforts aim to get addiction specialists on the job. Preconception hypertension poses pregnancy risks. And don’t leave transgender patients out of breast cancer surveillance. Listen to the MDedge Daily News podcast for all the details on today’s top news.
Could European data privacy rules cost you big? Synthetic opioids drive increases in overdose deaths. Robocalls increase diabetic retinopathy screenings in low-income patients. And a new ranking points physicians toward South Dakota.
Can androgen therapy improve male frailty? Empagliflozin could cut liver fat in diabetes. MicroRNAs might flag liver damage in HIV infection. And how triglycerides in cardiac muscle endanger women with HIV.
Why most heart failure may be preventable. Statins miss the mark in familial high cholesterol. Why mumps outbreaks are on the rise. And how using epileptic drugs in pregnancy affects school test scores.
Is kratom the answer to the opioid crisis? A simple screen may predict dementia in Parkinson’s disease. Should you fear steroids for inflammatory bowel disease? And specialists have adverse reactions to drug price proposals.